跳至主要内容
临床试验/TCTR20230113001
TCTR20230113001Unknown2 期

The effectiveness of intradermal platelet-rich plasma for the treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus), in Institute of dermatology, Thailand, pilot study

Institute of Dermatology0 个研究点目标入组 10 人开始时间: 2023年1月13日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 65 Years(—)
性别
All

入选标准

  • Patients between the ages of 25 and 65 with bilateral Hori's nevus

排除标准

  • 1. Pregnancy and breastfeeding
  • 2. History of PRP allergy
  • 3. History of bleeding disorder such as thalassemia or thrombocytopenia
  • 4. History of blood-borne disease include hepatitis B, hepatitis C or HIV
  • 5. Patient who currently on anti-oxidant supplement such as vitamin C, vitamin E within 3 months prior.
  • 6. Patient who got chemotherapy and anti-coagulant within three months prior to the study
  • 7. Patient who had done LASER or IPL within three months prior to the study
  • 8. Patient who concomitant use of whitening agents, chemical peeling within three months prior to the study
  • 9. Patient who significantly had co-existing hyperpigmented lesion except Hori's nevus
  • 10. Patient who has any active skin disease on the PRP injected area such as infection, skin cancer, dermatitis.

研究者

发起方
Institute of Dermatology

相似试验